Delivery Order SPE2DB20D1100-SPE2DB25FE1Z5
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Hydromorphone 1 mg/mL vials with a firm fixed price ceiling value of $2,013.12 and an ultimate completion date of August 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,144.88 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Hydromorphone 2 mg/ml, a narcotic pain management pharmaceutical. This firm fixed-price delivery order, which is expected to be completed by August 29, 2025, carries no set-aside designation and represents a competitively awarded transaction under open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $4,621.71 to AmerisourceBergen Drug Corp for the supply of Hydromorphone 1 mg/ml on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Hydromorphone is an opioid pain medication commonly used in military and veteran healthcare systems for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hydromorphone 1 mg/ml on June 18, 2025, with a ceiling value of $1,103.20 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with performance scheduled to conclude by June 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order represents a small-value pharmaceutical...
- AmerisourceBergen Drug Corp has been awarded a delivery order contract valued at $1,352.78 for the supply of Hydromorphone 1 mg/mL by the Defense Logistics Agency's Medical Supply Chain on August 6, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery is scheduled for completion by...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Hydromorphone HCL ER Tablets 16mg, with a contract ceiling value of $6,259.66 and a completion date of August 5, 2025. This competitive award, made without set-aside designation, is classified as a firm fixed price delivery order and represents a continuation of the federal government's ongoing pharmaceutical procurement through established...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.29 to AmerisourceBergen Drug Corp for the supply of Hydromorphone 0.5 mg/0.5 mL injectable solution. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,827.96 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 2, 2025, for the supply of Hydromorphone 1 mg/ml. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open solicitation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.20 to AmerisourceBergen Drug Corp for Hydromorphone HCL ER 8 mg tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $96,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 10 mg/ml vials of hydromorphone. The single day contract has a period of performance from September 27 through September 28, 2023, with all work to be conducted by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order falls under a larger blanket purchase...